• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Drug-Device Combinations

Abbott receives FDA warning letter related to FreeStyle Libre CGMs

February 3, 2026 By Sean Whooley

Abbott FreeStyle Libre 3 sensor pennies CGM diabetes

Abbott (NYSE:ABT) is facing an FDA warning letter alleging quality system regulation violations related to FreeStyle Libre CGM production. The FDA issued the letter on Jan. 23 and made it public today, Feb. 3. It relates to an inspection of Abbott’s Alameda, California, facility from Oct. 14, 2025, through Oct. 23, 2025. According to the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: abbott, FDA

Medtronic earns Medicare, FDA wins for MiniMed 780G with Instinct sensor, including for type 2 diabetes

February 2, 2026 By Sean Whooley

Medtronic MiniMed 780G insulin pump Abbott Instinct Sensor

Medtronic (NYSE:MDT) today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery system. The company announced Medicare access for MiniMed 780G paired with the Instinct sensor made by Abbott, FDA clearance for the pairing for insulin-requiring type 2 diabetes and FDA clearance for the system’s use with ultra rapid-acting insulins. Medtronic […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Centers for Medicare and Medicaid Services (CMS), FDA, Medtronic, minimed

MyLife Diabetes Care completes transition to independent company

January 30, 2026 By Sean Whooley

mylife loop camdiab ypsomed abbott freestyle libre 3

MyLife Diabetes Care announced that its transition into an independent company has now been formally completed. In August, Ypsomed announced that it completed the sale of its diabetes care business to TecMed AG. With this sale, the company transitioned MyLife from a business unit into a standalone company. This follows a recent medtech trend, with […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: MyLife Diabetes Care, TecMed, Ypsomed

Lilly to build $3.5B injectable medicine, device manufacturing plant in Pennsylvania

January 30, 2026 By Sean Whooley

Rendering of Eli Lilly facility in Lehigh Valley, PA (1)

Eli Lilly (NYSE:LLY) today announced plans to invest more than $3.5 billion to build a new manufacturing plant in Pennsylvania. The site, in Lehigh Valley, will serve as the company’s newest injectable medicine and device manufacturing facility. Indianapolis-based Lilly plans to produce next-generation weight-loss therapies there, including retatrutide, a first-in-class investigational GIP, GLP-1 and glucagon […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: Eli Lilly, Eli Lilly & Co.

Senseonics wins CE mark for Eversense 365 year-long CGM

January 29, 2026 By Sean Whooley

Senseonics Ascensia Eversense 365 product image separate components

Senseonics (NYSE:SENS) announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval. Germantown, Maryland-based Senseonics received FDA clearance for Eversense 365 in September 2024. It launched the year-long CGM implant with its global distribution partner, Ascensia Diabetes Care, the following month. It has since taken over full commercial activity for […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Implants, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Senseonics

Glucotrack picks up new patents for continuous blood glucose monitor

January 29, 2026 By Sean Whooley

Glucotrack 3-year continuous blood glucose monitor (CBGM)

Glucotrack (Nasdaq:GCTK) announced today that it received new U.S. patents for its continuous blood glucose monitoring (CBGM) platform. The U.S. Patent and Trademark Office (USPTO) issued Patent Nos. US 12,453,494, US 12,458,257 and US 12,458,258. These patents strengthen the company’s competitive position and intellectual property protection as it advances its CBGM system toward commercialization. Glucotrack’s […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Implants, Patient Monitoring, Technology Tagged With: Glucotrack

ViCentra picks former Insulet leader as VP, global marketing

January 29, 2026 By Sean Whooley

ViCentra VP Global Marketing Reman McDonagh

Insulin patch pump maker ViCentra announced today that it appointed Reman McDonagh as its VP, global marketing. The Utrecth, the Netherlands-based company said McDonagh’s appointment further strengthens its leadership team as it scales commercial execution across Europe. It also bolsters the company amid preparations for its next-generation Kaleido system, including expected European and U.S. launches. McDonagh’s […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel Tagged With: Personnel Moves, ViCentra

CraniUS closes $20M financing to support blood-brain barrier tech for drug delivery

January 28, 2026 By Sean Whooley

CraniUS NeuroPass device blood brain barrier

CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass. NeuroPass is a fully implantable, skull-embedded platform. The Baltimore-based company designed it to bypass the blood-brain barrier (BBB). It could enable targeted drug delivery and monitoring in the brain. CraniUS has NeuroPass under development […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Neurological Tagged With: CraniUS

Glaukos gets FDA nod for iDose TR re-administration

January 28, 2026 By Sean Whooley

Glaukos iDose

Glaukos (NYSE:GKOS) announced today that the FDA approved a new drug application (NDA) labeling supplement for its iDose TR system. iDose TR (travoprost intracameral implant) offers the reduction of intraocular pressure (IOP). It treats patients with ocular hypertension (OHT) or open-angle glaucoma (OAG). The first-of-its-kind, long-duration, intracameral procedural pharmaceutical therapy. It continuously delivers 24/7 therapeutic […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Glaukos

MannKind earns expanded FDA labeling for inhaled insulin

January 26, 2026 By Sean Whooley

MannKind afrezza inhaled insulin in use

MannKind (Nasdaq:MNKD) announced today that it received FDA approval for an update to the prescribing information for Afrezza inhaled insulin. Afrezza (insulin human) inhalation powder is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, mannkind

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Interim pages omitted …
  • Page 374
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS